This Article Full Text (PDF) A correction has been published References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (2) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Tzortzis, V. Articles by Melekos, M. D Search for Related Content PubMed PubMed Citation Articles by Tzortzis, V. Articles by Melekos, M. D Social Bookmarking                         What's this?

Sexual dysfunction in newly diagnosed multiple sclerosis women

Department of Urology, University of Thessaly School of Medicine, Larissa, Greece, tzorvas{at}otenet.gr

Konstantinos Skriapas

Department of Urology, University of Thessaly School of Medicine, Larissa, Greece

George Hadjigeorgiou

Department of Neurology, University of Thessaly School of Medicine, Larissa, Greece

Iraklis Mitsogiannis

Department of Urology, University of Thessaly School of Medicine, Larissa, Greece

Konstantinos Aggelakis

Department of Neurology, University of Thessaly School of Medicine, Larissa, Greece

Stavros Gravas

Department of Urology, University of Thessaly School of Medicine, Larissa, Greece

Vassilios Poulakis

Department of Urology, University of Thessaly School of Medicine, Larissa, Greece

Michael D Melekos

Department of Urology, University of Thessaly School of Medicine, Larissa, Greece

Objectives The aim of the study was to evaluate female sexuality in a selective population of newly diagnosed multiple sclerosis (MS) women.

Materials and methods In this clinic-based study, 63 newly diagnosed consecutive women affected by definite MS were admitted. Disability and depression were evaluated with the expanded disability status scale (EDSS) and Beck depression inventory, respectively. Sexual function was evaluated with the female sexual function index (FSFI). A group of 61 healthy female volunteers with the same baseline characteristics were used as controls. Postmenopausal women and patients with other major concomitant neurological, endocrinological, vascular, gynecological, psychiatric disorders, use of medicines that can cause female sexual dysfunction (FSD) and disease-modifying drugs were excluded from the study.

Results All the evaluated patients were ambulant with no major neurological impairment (mean EDSS score 2.5, range 0—3.5). None of the patients were considered clinically depressed, but some of them were sad or worried. According to the sexual history and FSFI scores, sexual dysfunction was diagnosed in 22 (34.9%) out of the 63 patients and in 13 (21.31%) out of the 61 healthy females (P > 0.05).

Conclusions In the newly diagnosed MS patients, FSD represent an important issue even though disability and other concomitant disorders affecting sexual function were excluded.

Multiple Sclerosis 2008; 14: 561—563. http://msj.sagepub.com

Key Words: sexual dysfunction • multiple sclerosis • FSFI

Multiple Sclerosis, Vol. 14, No. 4, 561-563 (2008)
DOI: 10.1177/13524585080140040901


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?